Bio-Thera Solutions' BAT2206 Biosimilar of Stelara Gains FDA Approval
CompanyDrug

Bio-Thera Solutions’ BAT2206 Biosimilar of Stelara Gains FDA Approval

Hainan Introduces New Pricing Rules for Digital Therapeutics Effective June 1
Policy / Regulatory

Hainan Introduces New Pricing Rules for Digital Therapeutics Effective June 1

Kanghong Pharma Wins NMPA Approval for KH617 in Glioblastoma Trial
CompanyDrug

Kanghong Pharma Wins NMPA Approval for KH617 in Glioblastoma Trial

Shandong Kanghua Biotechnology Announces IPO Plans on Beijing Stock Exchange
CompanyDeals

Shandong Kanghua Biotechnology Announces IPO Plans on Beijing Stock Exchange

Salubris Pharma Inks Licensing Deal for Gowell's GW906 in Greater China
CompanyDeals

Salubris Pharma Inks Licensing Deal for Gowell’s GW906 in Greater China

Walvax Biotechnology Secures Exclusive Rights to Notitia's Gut Microbiota Therapy
CompanyDeals

Walvax Biotechnology Secures Exclusive Rights to Notitia’s Gut Microbiota Therapy

Guangdong Zhongsheng Wins Peking University People's Hospital Nod for RAY1225 Phase III Trials
CompanyDrug

Guangdong Zhongsheng Wins Peking University People’s Hospital Nod for RAY1225 Phase III Trials

Jemincare's Irinotecan Liposome Injection Gains NMPA Approval for Pancreatic Cancer
CompanyDrug

Jemincare’s Irinotecan Liposome Injection Gains NMPA Approval for Pancreatic Cancer

Novo Nordisk's Wegovy Demonstrates Early Cardioprotective Effects in SELECT Trial
CompanyDrug

Novo Nordisk’s Wegovy Demonstrates Early Cardioprotective Effects in SELECT Trial

GSK's Blenrep Recommended for EU Approval in Multiple Myeloma
CompanyDrug

GSK’s Blenrep Recommended for EU Approval in Multiple Myeloma

Dizal Pharma Presents DZD8586 and DZD6008 Results at ASCO 2025
CompanyDrug

Dizal Pharma Presents DZD8586 and DZD6008 Results at ASCO 2025

Abbisko Therapeutics' FGFR4 Inhibitor Irpagratinib Granted Breakthrough Therapy Designation for HCC
CompanyDrug

Abbisko Therapeutics’ FGFR4 Inhibitor Irpagratinib Granted Breakthrough Therapy Designation for HCC